Skip to content
Screener

AptarGroup ATR Investing Cash Flow

Investing Cash Flow at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
-$43.2M+42.6%
Trimas logo
TrimasTRS
$1.43B+4,934%
Silgan Holdings logo
Silgan HoldingsSLGN
-$61.71M+2.6%
Amcor logo
AmcorAMCR
-$155M-34.8%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
-$62.66M
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$747.39M+3,190%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
In thousands, brackets denote cash outflows / Three Months Ended March 31,20262025
Purchases of short-term investments, net(103)(88)
Acquisition of intangible assets, net(592)(2,475)
Notes receivable, net(335)2,714
Net Cash Used by Investing Activities(65,099)(56,632)
Cash Flows from Financing Activities:
Proceeds from notes payable and overdrafts2,93079
Repayments of notes payable and overdrafts(2,895)
Proceeds and (repayments) of short-term revolving credit facility, net7,000(23,880)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's investing cash flow?
AptarGroup (ATR) reported investing cash flow of -$65.1M in Q1 2026.
How has AptarGroup's investing cash flow changed year-over-year?
AptarGroup's investing cash flow decreased by 15.0% year-over-year, from -$56.63M to -$65.1M.
What is the long-term trend for AptarGroup's investing cash flow?
Over 4 years (2021 to 2025), AptarGroup's investing cash flow has grown at a -7.7% compound annual growth rate (CAGR), from -$457.24M to -$331.43M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about AptarGroup's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude